Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer
Titel:
Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer
Auteur:
Kaufman, Peter A. Wildiers, Hans Freyer, Gilles Kemeny, Margaret Gonçalves, Anthony Jerusalem, Guy Stopeck, Alison Vrindavanam, Nandagopal Dalenc, Florence Nanayakkara, Nuwan Wu, Benjamin Pickett, Cheryl A.